1. Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
- Author
-
Harada K, Usui M, and Asai T
- Subjects
- Anti-Bacterial Agents pharmacology, Bacteriological Techniques, Ciprofloxacin pharmacology, Drug Resistance, Bacterial, Enrofloxacin, Japan, Actinobacillus pleuropneumoniae drug effects, Ciprofloxacin analogs & derivatives, Fluoroquinolones pharmacology, Mannheimia haemolytica drug effects, Pasteurella multocida drug effects
- Abstract
In this study, susceptibilities of Pasteurella multocida, Mannheimia haemolytica and Actinobacillus pleuropneumoniae to enrofloxacin and orbifloxacin were tested using an agar diffusion method with the commercial disks and a broth microdilution method. Good correlation between the 2 methods for enrofloxacin and orbifloxacin was observed for P. multocida (r = -0.743 and -0.818, respectively), M. haemolytica (r = -0.739 and -0.800, respectively) and A. pleuropneumoniae (r = -0.785 and -0.809, respectively). Based on the Clinical and Laboratory Standards Institute interpretive criteria for enrofloxacin, high-level categorical agreement between the 2 methods was found for P. multocida (97.9%), M. haemolytica (93.8%) and A. pleuropneumoniae (92.0%). Our findings indicate that the tested commercial disks can be applied for susceptibility testing of veterinary respiratory pathogens.
- Published
- 2014
- Full Text
- View/download PDF